DDAH1 and atherosclerosis: In summary, our findings demonstrate that DMY reduces lipid burden and inhibits atherosclerosis, at least in part, by decreasing miR‐21 expression and in turn activating DDAH1‐medaited ADMA‐eNOS‐NO pathway in ECs (Figure S5).